imiquimod sold brand name aldara among others medication acts immune response modifier used treat genital warts superficial basal cell carcinoma actinic scientists pharmaceuticals division discovered drug obtained first fda approval imiquimod generic available worldwide many brands imiquimod patientapplied cream prescribed treat genital warts bowens disease squamous cell carcinoma situ secondary surgery basal cell well actinic imiquimod cream indicated topical treatment imiquimod cream indicated topical treatment clinically typical nonhyperkeratotic nonhypertrophic visible palpable actinic keratosis full face balding scalp immunocompetent adults topical treatment options contraindicated less side effects include local inflammatory reactions blisters burning sensation skin redness dry skin itching skin breakdown skin crusting scabbing skin drainage skin flaking scaling skin ulceration sores swelling well systemic reactions fever flulike symptoms headache people organ transplant taking immunesuppressing drugs use imiquimod yields profound antitumoral activity acting several immunological levels imiquimod stimulates innate immune system activating tolllike receptor commonly involved pathogen cells activated imiquimod via secrete cytokines primarily interferonα ifnα tumor necrosis factorα evidence imiquimod applied skin lead activation langerhans cells subsequently migrate local lymph nodes activate adaptive immune cell types activated imiquimod include natural killer cells macrophages imiquimod exerts effect increasing levels opioid growth factor receptor ogfr experiments blocking ogfr function sirna technology resulted loss antiproliferative effect scientists pharmaceutical division discovered imiquimod part program discover inhibitors herpes simplex virus replication based known adenine obtained first fda approval treatment external genital perianal warts brand obtained fda approval market imiquimod treatment superficial basal cell sold pharmaceutical business americas graceway pharmaceuticals european pharmaceutical business meda ab pharmaceutical business territories two private equity graceway declared bankruptcy expiration patents imiquimod assets including rights imiquimod branding approvals americas purchased medicis imiquimod approved medical use european union september imiquimod approved medical use european union august imiquimod generic available worldwide many one randomized doubleblind phase iii clinical study found clearance genital warts fdaapproved indication improved placebo imiquimod cream applied eight imiquimod tested treatment molluscum contagiosum two large randomized controlled trials however found evidence effectiveness imiquimod treating children molluscum contagiosum concerning adverse effects also disprove earlier anecdotal claims smaller less reliable imiquimod also tested treatment vulvar intraepithelial vaginal intraepithelial common warts cochrane review found randomized controlled plantar warts people suppressed immune flat warts face warts around fingernails insufficient evidence exists recommend treatment warts genital warts imiquimod due small size lack controls existing httpsenwikipediaorgwikiimiquimod